Boston Scientific has announced a €75m investment in its Ballybrit Business Park site.
This will include the expansion of its research and development capabilities, which it says will further strengthen its role as a global centre for cardiovascular innovation.
The development, supported by IDA Ireland, includes purpose-built laboratories to enhance the design, development and testing of med-tech across a range of cardiovascular therapies.
Boston Scientific has been operating in Ireland for the last 30 years, with over 7,000 employees across sites in Galway, Cork and Clonmel.
